Magazine Article | August 2, 2018

Fibrocell: Where Gene Therapy Meets Synthetic Biology

Source: Life Science Leader

By Wayne Koberstein, Executive Editor, Life Science Leader
Follow Me On Twitter @WayneKoberstein

The Enterprisers: Life Science Leadership In Action

Biotechnology once meant only one thing — manufacturing human proteins by means of recombinant DNA applied to microorganisms, usually in fermentation. Now we speak of the life sciences, enlarging the world of biotech to encompass new technologies such as gene therapy and regenerative medicine. In The Enterprisers, as in the monthly Companies to Watch, I am now exploring that new ground, really a new geography of therapeutic areas joining and even cross-bordering with the pharmaceutical and biological therapeutics that always have been my beat. Fibrocell is developing therapeutics for rare skin disorders, using a new approach for gene therapy as a regenerative-medicine tool.

access the Magazine Article!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Life Science Leader

Please tell us more about you so that we can customize our newsletters to your specific interests: